Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Chimeron is biotech company focused on developing personalized gene therapies starting with cancer. At Chimeron Bio, we are committed to the development of our ChaESAR™ particle and RNA technology to bring forward innovative therapeutics across indications. Our current pipeline includes programs in oncology, liver and vaccines that are novel, highly differentiated and that stand to improve the lives of patients worldwide.

List your booth number for exhibitions, ask us